ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,969.34
0.35%
Dow Jones
44,296.51
0.97%
US Dollar vs MXN
20.4285
0.00%
Brent Oil
74.65
0.00%
Bitcoin
98,003.05
0.22%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. KBC Groep NV (KBC) Cotización

KBC Groep NV

KBC Groep NV (KBC)

Keybridge Capital Limited
68.70
-0.86
(-1.24%)
Cerrado 24 Noviembre 10:30AM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
68.70
Postura de Compra
67.82
Postura de Venta
69.50
Volume Operado de la Acción
379,853
67.78 Rango del Día 70.00
52.02 Rango de 52 semanas 72.36
Capitalización de Mercado [m]
28.064B
Precio Anterior
69.56
Precio de Apertura
69.78
Hora
167
@
68.7
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
466,311
Acciones en circulación
408,508,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
8.25
Beneficio por acción (BPA)
8.33
turnover
9.51B
Beneficio neto
3.4B

Acerca de KBC Groep NV

Sector
Title Insurance
Industria
Commercial Banks, Nec
Sitio web
www.kbc.com
Sede
Brussels, Brussels-capital Region, Bel
Fundado
2005
KBC Groep NV is listed in the Title Insurance sector of the Euronext with ticker KBC. The last closing price for KBC Groep NV was 69.56 €. Over the last year, KBC Groep NV shares have traded in a share price range of 52.02 € to 72.36 €.

KBC Groep NV currently has 408,508,000 shares in issue. The market capitalisation of KBC Groep NV is 28.42 € billion. KBC Groep NV has a price to earnings ratio (PE ratio) of 8.25.

KBC Últimas noticias

Más noticias

KBC Group: information regarding the traditional annual capital increase reserved for staff

KBC Group: information regarding the traditional annual capital increase reserved for staff KBC GROUP – 8 November 2024 – information regarding the traditional annual capital increase reserved for...

08 Noviembre 2024
UK Regulatory

KBC Groupe: Bénéfice de 868 millions d'euros pour le troisième trimestre

KBC Groupe: Bénéfice de 868 millions d'euros pour le troisième trimestre Aperçu KBC Groupe (consolidé, IFRS)3T20242T20243T20239M20249M2023Résultat net (en millions EUR)8689258772 3002...

07 Noviembre 2024
UK Regulatory

KBC Group: Third-quarter result of 868 million euros

KBC Group: Third-quarter result of 868 million euros KBC Group – overview (consolidated, IFRS)3Q20242Q20243Q20239M20249M2023Net result (in millions of EUR)8689258772 3002 725Basic earnings per...

07 Noviembre 2024
UK Regulatory

KBC Group: Publication of transparency notification(s) received by KBC Group NV

KBC Group: Publication of transparency notification(s) received by KBC Group NV Publication of transparency notification(s) received by KBC Group NV (art. 14, 1st section of the Act of 2 May 2007...

10 Octubre 2024
UK Regulatory

KBC Group: Notification for bondholders of KBC IFIMA

KBC Group: Notification for bondholders of KBC IFIMA Regulated information – 21 August 2024, 8u00 CEST Following document is available on www.kbc.com: 1H2024 financial report of KBC IFIMA

21 Agosto 2024
UK Regulatory

KBC Groupe: Résultat du deuxième trimestre: 925 millions d’euros

KBC Groupe: Résultat du deuxième trimestre: 925 millions d’euros Aperçu KBC Groupe (consolidé, IFRS)2TR20241TR20242TR20231S20241S2023Résultat net (en millions EUR)9255069661 4311 848Bénéfice de...

08 Agosto 2024
UK Regulatory

KBC Group: Second-quarter result of 925 million euros

KBC Group: Second-quarter result of 925 million euros KBC Group – overview (consolidated, IFRS)2Q20241Q20242Q20231H20241H2023Net result (in millions of EUR)9255069661 4311 848Basic earnings per...

08 Agosto 2024
UK Regulatory

KBC Group: Conclusion of the KBC Group share buyback programme. Transparency notification

KBC Group: Conclusion of the KBC Group share buyback programme. Transparency notification On 10 August 2023 after trading hours, KBC Group NV announced a share buyback programme. Within the...

02 Agosto 2024
UK Regulatory

KBC Groupe: Fin du programme de rachat d'actions propres du groupe KBC. Notification de transparence

KBC Groupe: Fin du programme de rachat d'actions propres du groupe KBC. Notification de transparence Le 10 août 2023, hors séance boursière, KBC Groupe SA a annoncé un programme de rachat...

02 Agosto 2024
UK Regulatory

KBC Group: Update regarding the KBC Group share buyback programme

KBC Group: Update regarding the KBC Group share buyback programme Within the framework of the share buyback programme announced on 10 August 2023 after trading hours, KBC Group NV wishes to advise...

02 Agosto 2024
UK Regulatory
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.84-1.2079378774869.5472.0667.7843298470.53444915DE
41.942.9059316956366.7672.0665.6845138569.09618438DE
12-1.62-2.3037542662170.3272.3665.6846631169.26151127DE
26-0.14-0.20337013364368.8472.3662.149260868.1377568DE
5216.5231.659639708752.1872.3652.0254180465.47870069DE
156-6.24-8.3266613290674.9485.0645.5362057161.92789755DE
2601.722.5679307255966.9886.533.4465159759.98691075DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MLAAHAmatheon Agri Holding NV
0.02 €
(100.00%)
5k
GNROGeNeuro SA
0.0768 €
(25.49%)
200
BIDSGascogne DS
0.005 €
(25.00%)
150.51k
ALSAFSAFE
0.11 €
(23.73%)
39.98k
ALKKOKKO International SA
0.112 €
(21.21%)
4.13M
ALIMOGroupimo
0.189 €
(-40.94%)
392
MLUMGUmalis Group
1.30 €
(-31.22%)
1.71k
MLNMAMiguet Et Associes
0.075 €
(-24.62%)
1.72k
MLSEQSequa Petroleum NV
0.008 €
(-20.00%)
23k
VACBSPierre & Vacances
0.05 €
(-15.25%)
35.99k
BCPBanco Comercial Portugues SA
0.4446 €
(-0.49%)
69.24M
ALNEVNeovacs
0.0002 €
(0.00%)
41.4M
ALCYBCybergun
0.0001 €
(0.00%)
30.32M
INGAING Groep NV
14.652 €
(-1.16%)
14.06M
ACACredit Agricole SA
13.05 €
(-1.66%)
8.06M

Discusión

Ver feed completo
rawsteel rawsteel 2 minutos hace
It was 9,999,999 buy or sell until just recently. Don't know when it changed exactly. You can still put in a sell order under 10mil but buying is a different story. I couldn't buy over 142k of ADHC last week but it is135k today to put in a buy order
ADHC
RuudSaltis RuudSaltis 5 minutos hace
That is a strong buy recommendation!!
LWLG
tommydoyle.me2 tommydoyle.me2 17 minutos hace
.
Truthsocial Truthsocial 35 minutos hace
Can someone who cares do a wellness check on sceeat...family members FDA or BIG Pharma please

Because RDGL and MAYO clinic are soon ready to move up in the outpatient cancer treatment world without sceeat....
RDGL
The ELTP King The ELTP King 36 minutos hace
This is my last post.

Taking a long break for the holidays.

Will return in early January.

Thanks.
ELTP
Murphydog25 Murphydog25 37 minutos hace
Just gave Hitman a DM to talk about this stock going forward so I'm feeling more positive now after his positive words of wisdom 🤗
He also said he's doing well but finding 6 by 6 a small space and his flatmate ron'da snores 🧐
NWPN
Azart Azart 49 minutos hace
My friend what Scamus is currently doing is absolutely not new. This is exactly how everything was transferred from the previous company to becoming Rannever Health back in 2014 or 15 if I am not mistaken. The back then CEO before Scamus did the exact same thing Scamus is doing with Foxo. Common hol
RNVA
SteveSchiets SteveSchiets 54 minutos hace
There was a lot of resistance not acting up on my belief S7 hasn't play it's final hand. The fact that ACC's are used by our competitors made me do that silly thing. Maybe also because other stocks in my portfolio needs more time, i decided to have one last go (it's never the last). If trillions wi
SEV
knrorrel knrorrel 2 horas hace
no chance in the quantum hype, $10 could come quickly now, like on Friday with qmco (+171%, only on Friday increased from $3.60 to $11!)

and it's a shame that they couldn't buy more,

but I feel the same way (I also have far too little of $QBTS but unfortunately I don'
QBTS
chen1992 chen1992 2 horas hace
https://youtu.be/PaMsc8z1Ls4?si=u3MwvbGovNMyWXI6


Inverse Cramer at it again! Did it for TELL!!!!
TGLO
silkmaster silkmaster 2 horas hace
It looks like we can only guss what would the pps will look like in a week/month or a year from now .
Mean while lets play what would the PPS look like come 30/11/24 so long as KT will come out and talk to the public by than that is ...

A. 0.09 (around current pps)
B. 0.
KBLB
ZLAZARUS ZLAZARUS 2 horas hace
Ph3 melanoma data for IO102-IO103 remain on track for 1H25 and represents the next key catalyst. At .70 we are trading at cash. With a positive Ph3 melanoma readout we will be trading at $3.00 overnight with a march to $6.00 towards the later half of 2025. In addition, I'm encouraged by the support
IOBT
knrorrel knrorrel 2 horas hace
https://de.tradingview.com/chart/Mq3nUQ7Y/?symbol=NYSE%3AQBTS
QBTS
knrorrel knrorrel 2 horas hace
friday +171% / $11 and $Q_BTS follows on Monday, which is much better than QMCO and still has a lot of potential to trade above $10 ?
all only imho

here: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175432596


QMCO
Whalatane Whalatane 2 horas hace
Yes There will be less of a reaction in the UNCY stock for the reason you mentioned
ARDX is saying they will supply Xphozah free of charge to Medicare patients who lose coverage in Jan ...for the first 2 mths only
Nephrologists are probably already pulling back from starting Medicare
ARDX UNCY
SCAMBUSTERKING SCAMBUSTERKING 2 horas hace
My statements are backed up by the court docs filed by Jake and his lawyer... then even more proven by the actions of Jake.
BCAP
chereb19 chereb19 2 horas hace
An even bigger Whopper of a lie. Can't believe anything you write, there's are too many examples of your lies. Dishonest and incompetent?
RDGL
knrorrel knrorrel 2 horas hace
THE $QBTS TREND https://stockcharts.com/sc3/ui/?s=QBTS
QBTS
weedtrader420 weedtrader420 2 horas hace
☝️🤑☝️📈🚀
SUKUUSD
knrorrel knrorrel 3 horas hace
THE $QBTS TREND https://stockcharts.com/sc3/ui/?s=QBTS
QBTS
fuagf fuagf 3 horas hace
And all should understand subsidies discourage innovation leading to efficiency.
You're right too, we are talking about corporate farming in that respect also.
Ray_137 Ray_137 3 horas hace
That can be true plan 7 contains some parts of plan6. Investors in WAMU signed releases based on plan7.
COOP

Su Consulta Reciente

EU
KBC
KBC Groep NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados